American Lung Association

Funding Organization

Awards Grant

  • ANDDi - American Lung Association Novel Digital Diary Trial
  • Acrolein Induced CFTR Dysfunction as a Therapeutic Target in Chronic Bronchitis
  • Airways Clinical Research Center (ACRC)
  • Airways Clinical Research Centers (ACRC)
  • Airways Clinical Research Centers (ACRC) Network
  • Airways Clinical Research Centers (ACRC) Network
  • Airways Clinical Research Centers (ALA-ACRC) Network
  • Airways Clinical Research Centers (ALA-ACRC) Network
  • Asthma BMI Baseline Study (ABBS)
  • BI LHC Supplemental Grant: (Boehringer Ingelheim) Lung Health Cohort Supplemental Grant
  • Characterization of a Mycobacterium Tuberculosis Porin with an Autotransporter-Like Toxin Activity
  • Chronic Refractory Cough Cohort Study (COCO) Trial
  • Cigarette Smoke and Drug Resistant Tuberculosis
  • Effect of E-Cigarette Derived Reactive Aldehydes on Airway Inflammation
  • Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma
  • Losartan Effects on Emphysema Progression (LEEP) COVID-19 Ancillary Study
  • Markers of Lung Degradation and Emphysema: A Pilot Study
  • Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) LEEP (Losartan Effects on Emphysema Progression) Trial
  • Novel SARS-CoV-2 Antivirals Targeting Viral Encoded Ion Channels
  • Regulation of the Degradation of Cystic Fibrosis Transmembrane Conductance Regulator under Cystic Fibrosis Conditions
  • Risk of Hospital-acquired Pneumonia is Increased by Cigarette Smoke-induced Impaired Host Defense
  • Systemic CFTR Dysfunction Induced by Acrolein in Cigarette Smoke: A Novel Therapeutic Target for COPD
  • Trial of Roflumilast in Asthma Management (TRIM) Study